CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Oliver Kayser - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Oliver Kayser

OPENALEX: A5059661591↗ORCID: 0000-0001-6131-2495↗

Affiliations

Organizations

TU Dortmund Universityauthorship · DE

Public evidence

6 connected articles

Anti-Infective Screening of Selected Nine Cannabinoids Against <i>Clostridium perfringens</i> and Influenza A (H5N1) Neuraminidases, and SARS-CoV-2 Main Protease and Spike Protein Interactions.2025 · Europe PMC Integrated omics of Saccharomyces cerevisiae CENPK2-1C reveals pleiotropic drug resistance and lipidomic adaptations to cannabidiol.2024 · Europe PMC Bioengineering studies and pathway modeling of the heterologous biosynthesis of tetrahydrocannabinolic acid in yeast.2020 · Europe PMC Virus-induced gene silencing (VIGS) in Cannabis sativa L.2019 · PubMed Central Open Access Chemical fingerprinting of single glandular trichomes of Cannabis sativa by Coherent anti-Stokes Raman scattering (CARS) microscopy.2018 · Europe PMC Designing microorganisms for heterologous biosynthesis of cannabinoids.2017 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.